Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2014
06/10/2014CA2625506C Immuno-stimulant combination for prophylaxis and treatment of hepatitis c
06/10/2014CA2544409C Use of il-6-type cytokines for maturation of oocytes
06/10/2014CA2507373C Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases
06/10/2014CA2502029C Site specific incorporation of keto amino acids into proteins
06/10/2014CA2482810C Teneurin c-terminal associated peptides (tcap) and methods and uses thereof
06/10/2014CA2482634C Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
06/10/2014CA2481318C Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
06/10/2014CA2459816C Hybrid and tandem expression of neisserial proteins
06/10/2014CA2441287C Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
06/10/2014CA2399280C Defects in periaxin associated with myelinopathies
06/10/2014CA2326598C Fusion proteins of mycobacterium tuberculosis antigens and their uses
06/10/2014CA2300364C Prostate tumor polynucleotide and antigen compositions
06/05/2014WO2014085767A1 Compositions and methods for treating immune conditions, including type1 diabetes
06/05/2014WO2014085676A1 Ron compositions and methods of use thereof
06/05/2014WO2014085641A1 Pigment structures, pigment granules, pigment proteins, and uses thereof
06/05/2014WO2014085637A1 New lantibiotic derivatives and a process for their preparation
06/05/2014WO2014085621A1 Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
06/05/2014WO2014085616A1 Computationally optimized broadly reactive antigens for h1n1 influenza
06/05/2014WO2014085419A1 Engineering the production of a conformational variant of occidiofungin that has enhanced inhibitory activity against fungal species
06/05/2014WO2014085365A2 Compositions and methods for treatment of metabolic disorders and diseases
06/05/2014WO2014085251A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/05/2014WO2014084421A1 Bile acid oligomer conjugate for novel vesicular transport and use thereof
06/05/2014WO2014084372A1 Polypeptide and imaging method
06/05/2014WO2014083518A2 Designing a soluble full-length hiv-1 gp41 trimer
06/05/2014WO2014083510A1 Monolith-based pseudo-bioaffinity purification methods for factor viii and applications thereof
06/05/2014WO2014083301A1 Transgenic plants with altered sumoylation
06/05/2014WO2014083233A1 Microparticles with egf, method of preparation and use
06/05/2014WO2014083173A1 Tumor specific t-cell receptors
06/05/2014WO2014083060A2 Pseudomonas antigens and antigen combinations
06/05/2014WO2014083058A1 Combination therapy with volasertib
06/05/2014WO2014083040A2 Progranulin as marker for autoimmune disorders
06/05/2014WO2014083004A1 Removal of cancer cells by circulating virus-specific cytotoxic t-cells using cancer cell targeted mhc class i comprising multi-function proteins
06/05/2014WO2014082513A1 Lipase and use thereof
06/05/2014WO2014082293A1 Cotton zinc finger protein (czf6) and coding gene and use thereof
06/05/2014WO2014082285A1 Cotton zinc finger protein (czf5) and coding gene and use thereof
06/05/2014WO2014082280A1 Cotton zinc finger protein (czf4) and coding gene and application thereof
06/05/2014WO2014082184A1 Targeted iduronate-2-sulfatase compounds
06/05/2014WO2014036412A3 A method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor
06/05/2014WO2007141778A3 Development of follicle stimulating hormone agonists and antagonists in fish
06/05/2014US20140157459 Pesticidal gene and use thereof
06/05/2014US20140157458 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis
06/05/2014US20140155580 Transgenic aves producing human polyclonal antibodies
06/05/2014US20140155578 Variant sucrose transporter polypeptides
06/05/2014US20140155576 F11 receptor (f11r) antagonists as therapeutic agents
06/05/2014US20140155496 Templated Native Silk Smectic Gels
06/05/2014US20140155476 SIMIAN SUBFAMILY E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38 AND USES THEREOF
06/05/2014US20140155474 Modified polynucleotides for treating cystic fibrosis
06/05/2014US20140155470 Pla2r1 as anti-tumoral compound and as biomarker for the detection of cancer
06/05/2014US20140155331 Novel high affinity bivalent helically constrained peptide against cancer
06/05/2014US20140155330 Compositions And Methods For Modulating Apoptosis
06/05/2014US20140155329 Long-Acting Peptide Analogs
06/05/2014US20140155328 Alpha-and gamma-msh analogues
06/05/2014US20140155326 Egfr and c-met fibronectin type iii domain binding molecules
06/05/2014US20140155325 Egfr and c-met fibronectin type iii domain binding molecules
06/05/2014US20140155324 Novel peptides and uses thereof in therapeutic methods
06/05/2014US20140155323 Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
06/05/2014US20140155318 Peptides and compositions for prevention of cell adhesion and methods of using same
06/05/2014US20140155317 Selectively targeted antimicrobial peptides and the use thereof
06/05/2014US20140155290 Host cells comprising alpha 1, 2 mannosidase and culture methods thereof
06/05/2014US20140155288 Methods for diagnosing cancer
06/05/2014US20140154803 Anti-inflammatory proteins and methods of preparation and use thereof
06/05/2014US20140154743 Methods and materials for enhancing functional protein expression in bacteria
06/05/2014US20140154738 Protein glycosylation modification in methylotrophic yeast
06/05/2014US20140154707 N-glycosylation in transformed phaeodactylum tricornutum
06/05/2014US20140154704 Monoclonal Antibodies with Specficity for Fetal Erythroid Cells
06/05/2014US20140154308 Microparticle Formulations for Delivery to the Upper and Central Respiratory Tract and Methods of Manufacture
06/05/2014US20140154286 Modified biotin-binding protein, fusion proteins thereof and applications
06/05/2014US20140154283 Identification of a west nile virus cd4 t cell epitope and use thereof
06/05/2014US20140154280 Fusion proteins for use as immunogenic enhancers for inducing antigen-specific t cell responses
06/05/2014US20140154279 Peptides capable of modulating the function of tirc7
06/05/2014US20140154271 Methods of Treating Glucose Metabolism Disorders
06/05/2014US20140154260 B-7 related nucleic acids and polypeptides useful for immunomodulation
06/05/2014US20140154248 Recombinant immunotoxin targeting mesothelin
06/05/2014US20140154243 Specific binding agents to hepatocyte growth factor
06/05/2014US20140154238 Compositions And Methods For Treating, Diagnosing And Monitoring Disease
06/05/2014US20140154231 Process for separating proteins fibrinogen, factor xiii and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
06/05/2014US20140154214 Selective glucagon-like-peptide-2 (glp-2) analogues
06/05/2014US20140154213 Recombinant vector for producing and secreting peptide or protein of interest by propionibacteria and applications thereof
06/04/2014EP2738257A1 Compositions and methods for producing bioactive fusion proteins
06/04/2014EP2738255A1 Erap1-derived peptide and use thereof
06/04/2014EP2738253A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct
06/04/2014EP2737913A1 Thermosensitive, bioactive biopolymer and associated method of cell harvesting
06/04/2014EP2737906A1 Therapeutic vaccines
06/04/2014EP2737895A1 Microparticles with EGF, method of preparation and use
06/04/2014EP2737311A1 Assays to monitor bleeding disorders
06/04/2014EP2737069A1 Axmi205 variant proteins and methods for their use
06/04/2014EP2737068A1 Axmi279 pesticidal gene and methods for its use
06/04/2014EP2737065A2 Protein production method
06/04/2014EP2737059A1 Novel prrs virus inducing type i interferon in susceptible cells
06/04/2014EP2737050A2 Recombinant apoa-1m from engineered bacteria
06/04/2014EP2736924A1 Antimicrobial peptide produced by intestinal lactobacillus salivarius
06/04/2014EP2736923A1 Axmi270 toxin gene and methods for its use
06/04/2014EP2736922A1 Prevention of salmonella recrudescense
06/04/2014EP2736921A1 Compositions and methods for assessing functional immunogenicity of parvovirus vaccines
06/04/2014EP2736533A2 Selective delivery molecules and methods of use
06/04/2014EP2736524A1 Purified proteins
06/04/2014CN1867667B Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
06/04/2014CN1849397B Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
06/04/2014CN103842823A Molecular marker for early indentification of pleural mesothelioma patients, and expression analysis method for same
06/04/2014CN103842378A Proteinaceous protease inhibitor and protein solution and detergent composition containing it
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 2916